1 / 32

Team IPO: System for quantifying K-Level assessment in amputees

Team IPO: System for quantifying K-Level assessment in amputees. Connor Bortz , Matthew Galbraith, Jessica Lewis, Chelsea Madden, Anthony Rossi. Background Summary. $50,000. $5,000. Background Summary. K-Level system for rating amputee assessment: K-0: D oes N ot Qualify.

garima
Download Presentation

Team IPO: System for quantifying K-Level assessment in amputees

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Team IPO: System for quantifying K-Level assessment in amputees Connor Bortz, Matthew Galbraith, Jessica Lewis, Chelsea Madden, Anthony Rossi

  2. Background Summary $50,000 $5,000

  3. Background Summary • K-Level system for rating amputee assessment: • K-0: Does Not Qualify. • K-1: Fixed-pace on level ground. • K-2: Walk over minor barriers. • K-3: Varied-cadence and over most barriers. • K-4: Athletic Ability with Prosthetic.

  4. Background Summary • Too qualitative. • Distinction between K-2 to K-3 • Initiative to ‘work their way up’

  5. Scope To develop a system to measure various gait parameters that pertain to ambulating to be used for diagnosis justification, and prosthetic prescription.

  6. Product Desired Specifications • Constraints • Product must abide by any FDA, FCC, or other existing codes and regulations. • Project must make substantial progress towards use on amputee subjects before final deadline, December 11th. • Project must be compatible with existing prostheses.

  7. Product Desired Specifications 1.) Measuring Capabilities 2.) Data Acquisition/Storage 3.) Low-Cost 4.) Portability 5.) Comfort 6.) Water-proof 7.) User-Readability 8.) Aesthetic • Wants:

  8. Product Desired Specifications • Within “Measuring Capabilities”, there are prioritized parameters: 1.) Number of Steps 2.) Walking Cadence 3.) Distance 4.) Elevation detection. K-1: K-2: K-3:

  9. Metrics

  10. Benchmarking Software Data Analysis Hardware

  11. Hardware Options Actibelt® Fitbit® One TM Worn around the body Available for purchase Data readout on device ~$99.99 per device In-House Manufacturing • Labor intensive • Unknown timetable • Custom software required • Cost undetermined • Worn around the hip • Available for rent • Readout software included • ~$260 per belt per month

  12. Hardware Selection - For Hardware: FitBit® OneTM best fits the metrics for the desired specifications

  13. Software Options Fitabase Fitbit®OneTM Online Online software provided byFitbit® Intraday data available in fifteen minute intervals No customization allowed Custom Software • Requires registering with Fitbit® • Google Doc has embedded Fitbit®extraction • Data intervals in day-by-day basis • Intraday data available inminute intervals • Customizable user interface

  14. Software Selection - For Software: Fitabase best fits the metrics for the desired specifications

  15. Final Design Fitabase Fitbit®OneTM Software Development

  16. Test Plan Hardware Testing: Verify standard Fitbit® outputs for normal and amputee subjects Software Testing: Validate desired system outcomes, e.g. minute-by-minute step count, stair climb, change in cadence, in normal subjects Clinical Trials: Field testing of integrated hardware and software system on cohort of amputees with a range of K-levels

  17. Hardware Testing: Healthy Subjects • 2 healthy subjects (M 22 yo, F 21 yo) • Walking tests on treadmill & stairs • Fast/slow cadence • Flat & incline • Location of FitBit® • Outcomes from Fitbit® software (15-minute intervals) • Step count • Distance • Floors

  18. Hardware Testing: Healthy Subjects • Fitbit® Measurement Error (across all trials) • Steps: 11±13% • Floors: 0% • Observations • Incline only measured with change in elevation • Cadence not a direct output Example of standard output from Fitbit®

  19. Hardware Testing: Amputee Subjects • 1 amputee subject (M, 39 yo) • Walking tests outside • Walking test (30 steps) • Stair test (1 flight of stairs) • Results: Accuracy • Step Count = 93.75% • Stair Climb = 100%

  20. Test Plan ✔ Hardware Testing: Verify standard Fitbit® outputs for normal and amputee subjects Software Testing: Validate desired system outcomes, e.g. minute-by-minute step count, stair climb, change in cadence, in normal subjects Clinical Trials: Field testing of integrated hardware and software system on cohort of amputees with a range of K-levels

  21. Software Test #1 • 3 healthy subjects (M, 21-22 yo) • Walking tests on indoor track & stairs • Fast/slow cadence • With/without obstacles • Pedometer & observation as gold standard • Outcomes from Fitabase® (min-by-min) • Step count • Distance • Elevation

  22. * Data shown for Subject 2, 9 min walk on flat ground with change in cadence every 3 min

  23. Software Test #2 • 3 healthy subjects (M 21 yo, 2xF 21 yo) • Walking tests • Simulated daily activity outside/inside with obstacles • Random changes in cadence • Cadence change as primary outcome • Blinded data analysis • Varied threshold for detecting change in cadence • Error in predicted versus actual change in cadence

  24. ★ ★ ★ ★ ★ ★ * Data shown for Subject 3, 23 min. walk test in native environment with subject-selected change in cadence

  25. Test Plan ✔ Hardware Testing: Verify standard Fitbit® outputs for normal and amputee subjects Software Testing: Validate desired system outcomes, e.g. minute-by-minute step count, stair climb, change in cadence, in normal subjects Clinical Trials: Field testing of integrated hardware and software system on cohort of amputees with a range of K-levels ✔

  26. Clinical Trials: Methods • Subjects • 60 Amputees: K-1 (15), K-2 (15), K-3 (15), K-4(15) • 20 Healthy controls • Walking tests • Clinical assessment: 6-minute walk test, 10m test • Normal daily activity for a week • Outcome Measures • Patient records • Clinical assessment • Custom outcomes from Fitabase • User survey University of Delaware Internal Review Board (IRB) approved November 20th

  27. Clinical Trials: Hypotheses • The system can be used to observe cadence changes and elevation changes • The system will be well tolerated by the patients • Threshold for detection of cadence change will vary between normal and amputee subjects and can be incorporated into the design

  28. Project Cost

  29. Metrics ✔ ✔ ✔ ✔ ✔ ✔

  30. Path Forward • Business negotiations for intellectual property between Fitabaseand IPO • Run clinical trials in Spring 2014 (UD MEEG482) • Academic publication of clinical trials in Summer 2014 • Distribution of software to other prosthetics clinics through Fitabase 2014-2015 • World Tour 2014-2015

  31. Acknowledgments John Horne, Sponsor Dr. Buckley, Advisor Entire Senior Design Staff Thank you for your attendance!

More Related